Compumedics (ASX:CMP) Forward PE Ratio: 6.49 (As of Jun. 28, 2026)


ASX:CMP Compumedics Ltd ASX:CMP
61 GF Score
Price A$0.24
GF Value A$0.31
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Compumedics Forward PE Ratio?

Compumedics ASX:CMP -4.00% 61 Forward PE Ratio is 6.49 as of Jun. 28, 2026. GuruFocus rates ASX:CMP with a GF Score™ of 61/100 and a GF Value™ of A$0.31 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 392 Medical Devices & Instruments companies, Compumedics ranks better than 92.09% on this metric.

Compumedics's Forward PE Ratio for today is 6.49.

Compumedics's PE Ratio without NRI for today is 0.00.

Compumedics's PE Ratio (TTM) for today is 0.00.


Compumedics  (ASX:CMP) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Compumedics Forward PE Ratio Related Terms


Compumedics Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Compumedics's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compumedics Forward PE Ratio Chart

Compumedics Annual Data
Trend
Forward PE Ratio

Compumedics Semi-Annual Data
2025-12
Forward PE Ratio 25.67

ASX:CMP vs ABT, SYK, MDT: Forward PE Ratio Comparison

For the Medical Devices subindustry, Compumedics's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Compumedics Forward PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Compumedics's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Compumedics's Forward PE Ratio falls into.


ASX:CMP
61GF Score
Compumedics Ltd ASX:CMP
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compumedics Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 6.49 mean?
Compumedics (ASX:CMP) has a Forward PE Ratio of 6.49 as of Jun. 28, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Compumedics and its competitors. According to the industry distribution chart, Compumedics ranks #31 out of 392 companies in the Medical Devices & Instruments industry, placing it in the top 7.9%.
Is Compumedics' Forward PE Ratio too high?
Compumedics' current Forward PE Ratio is 6.49. The Medical Devices & Instruments industry median Forward PE Ratio is 18.88. Compumedics' value of 6.49 is 65.6% below this industry median. Based on the distribution chart, Compumedics ranks #31 out of 392 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Compumedics has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Compumedics' Forward PE Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Compumedics ranks #31 out of 392 companies for Forward PE Ratio. This places Compumedics in the top 8% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 18.88. Compumedics' value of 6.49 is 65.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 18.88, based on 392 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Compumedics's current Forward PE Ratio of 6.49 is 65.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Compumedics and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 18.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Compumedics's current Forward PE Ratio is 6.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compumedics stock overvalued right now?
Based on GuruFocus' analysis, Compumedics (ASX:CMP) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.31, compared to a current price of A$0.24 — trading 22.6% below its estimated fair value. The current Forward PE Ratio is 6.49 and 65.6% below the Medical Devices & Instruments industry median of 18.88. Compumedics' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Compumedics (ASX:CMP), the current Forward PE Ratio is 6.49 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Compumedics (ASX:CMP) Overvalued in 2026?

Based on GuruFocus' analysis, Compumedics stock appears to be undervalued. The current stock price of A$0.24 is trading 22.6% below its estimated GF Value™ of A$0.31. GuruFocus considers Compumedics to be Modestly Undervalued.

Key valuation signals for ASX:CMP:

  • Forward PE Ratio: 6.49
  • GF Value™: A$0.31 vs. price of A$0.24 (22.6% below fair value)
  • GF Score™: 61/100 with 6 warning signs
  • Industry Position: 65.6% below the Medical Devices & Instruments median (#31 of 392)

No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Compumedics Business Description

Address 30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
61GF Score

Get the complete analysis for ASX:CMP

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.24
Price
A$0.31
GF Value